Focal Reduction in Cardiac 123 I-Metaiodobenzylguanidine Uptake in Patients With Anderson-Fabry Disease

It remains to be elucidated whether cardiac sympathetic nervous activity is impaired in patients with Anderson-Fabry disease (AFD). We performed I-meta-iodobenzylguanidine (MIBG) scintigraphy and gadolinium-enhanced cardiovascular magnetic resonance (CMR) in 5 AFD patients. MIBG uptake in the infero...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Circulation journal : official journal of the Japanese Circulation Society 2016-11, Vol.80 (12), p.2550
Hauptverfasser:	Yamamoto, Saori, Suzuki, Hideaki, Sugimura, Koichiro, Tatebe, Shunsuke, Aoki, Tatsuo, Miura, Masanobu, Yaoita, Nobuhiro, Sato, Haruka, Kozu, Katuya, Ota, Hideki, Takanami, Kentaro, Takase, Kei, Shimokawa, Hiroaki
Format:	Artikel
Sprache:	eng
Schlagworte:	3-Iodobenzylguanidine - administration & dosage 3-Iodobenzylguanidine - pharmacokinetics Fabry Disease - diagnostic imaging Fabry Disease - metabolism Female Gadolinium - administration & dosage Gadolinium - pharmacokinetics Humans Magnetic Resonance Imaging Male Myocardium - metabolism Radionuclide Imaging
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!